Literature DB >> 12486137

Peptide ligands for the fibronectin type II modules of matrix metalloproteinase 2 (MMP-2).

Maria Trexler1, Klára Briknarová, Marion Gehrmann, Miguel Llinás, László Patthy.   

Abstract

The interaction of matrix metalloproteinase 2 (MMP-2) with gelatin is mediated by three repeats homologous to fibronectin type II (FN2) modules, which are inserted in the catalytic domain in proximity of the active site. We screened a random 15-mer phage display library to identify peptides that interact with the FN2 modules of MMP-2. Interestingly, the selected peptides are not gelatin-like and do not share a common, obvious sequence motif. However, they contain a high proportion of aromatic residues. The interactions of two peptides, WHWRH0RIPLQLAAGR and THSHQWRHHQFPAPT, with constructs comprising the in-tandem first and second and second and third FN2 modules of MMP-2 (Col-12 and Col-23, respectively) were characterized by NMR. Both peptides interact with Col-12 and Col-23 with apparent association constants in the mm(-1) range. Peptide binding results in perturbation of signals from residues located in the gelatin-binding pocket and flexible parts of the molecule. Although the former finding suggests that the gelatin-binding site is involved in the contact, the interpretation of the latter is less straightforward and may well reflect both the direct and indirect effects of the interaction.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12486137     DOI: 10.1074/jbc.M210116200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  11 in total

1.  Immunohistochemical and transcriptional expression of matrix metalloproteinases in full-term human umbilical cord and human umbilical vein endothelial cells.

Authors:  Annamaria Mauro; Maria Buscemi; Aldo Gerbino
Journal:  J Mol Histol       Date:  2010-10-10       Impact factor: 2.611

2.  Histochemical examination of cathepsin K, MMP1 and MMP2 in compressed periodontal ligament during orthodontic tooth movement in periostin deficient mice.

Authors:  Shengyu Lv; Hongrui Liu; Jian Cui; Tomoka Hasegawa; Hiromi Hongo; Wei Feng; Juan Li; Bao Sun; Akira Kudo; Norio Amizuka; Minqi Li
Journal:  J Mol Histol       Date:  2013-11-08       Impact factor: 2.611

Review 3.  Matrix metalloproteinases as potential targets in the venous dilation associated with varicose veins.

Authors:  Arda Kucukguven; Raouf A Khalil
Journal:  Curr Drug Targets       Date:  2013-03       Impact factor: 3.465

4.  Implications for collagen binding from the crystallographic structure of fibronectin 6FnI1-2FnII7FnI.

Authors:  Michèle C Erat; Ulrich Schwarz-Linek; Andrew R Pickford; Richard W Farndale; Iain D Campbell; Ioannis Vakonakis
Journal:  J Biol Chem       Date:  2010-08-24       Impact factor: 5.157

Review 5.  Role of matrix metalloproteinase inhibitors in preventing abdominal aortic aneurysm.

Authors:  Faisal Aziz; Helena Kuivaniemi
Journal:  Ann Vasc Surg       Date:  2007-05       Impact factor: 1.466

6.  Nuclear magnetic resonance mapping and functional confirmation of the collagen binding sites of matrix metalloproteinase-2.

Authors:  Xiaoping Xu; Margarita Mikhailova; Udayar Ilangovan; Zhihua Chen; Agnes Yu; Sanjay Pal; Andrew P Hinck; Bjorn Steffensen
Journal:  Biochemistry       Date:  2009-06-30       Impact factor: 3.162

Review 7.  In vivo cancer biomarkers of esophageal neoplasia.

Authors:  Shaoying Lu; Thomas D Wang
Journal:  Cancer Biomark       Date:  2008       Impact factor: 4.388

8.  Inhibition of MMP-2 gelatinolysis by targeting exodomain-substrate interactions.

Authors:  Xiaoping Xu; Zhihua Chen; Yao Wang; Lynda Bonewald; Bjorn Steffensen
Journal:  Biochem J       Date:  2007-08-15       Impact factor: 3.857

Review 9.  Molecular nanotechnologies of gelatin-immobilization using macrocyclic metal chelates.

Authors:  Oleg V Mikhailov
Journal:  Nano Rev       Date:  2014-02-07

10.  Miguel Llinás and the Structure of the Kringle Fold.

Authors:  Laszlo Patthy
Journal:  Protein J       Date:  2021-03-31       Impact factor: 2.371

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.